ebei, B., Nikoli, V., Sikiri, P., Seiwerth, S., oa, T., Patrlj, L., Grabarevi, ., Ruman, R., Petek, M., Konjevoda, P., Jadrijevi, S., Perovi, D., & laj, M
BPC-157 is not FDA-approved for any medical condition, including soft-tissue injury, gut healing, pain, inflammation, anti-aging, or performance enhancement
Patients must provide informed consent acknowledging the off-label, evidence-limited nature of this therapy
Key Research Highlights Dual-peptide blend pairing BPC-157 (pentadecapeptide) with TB-500 (Thymosin Beta-4 analogue) Studied in vitro for cytoskeletal / actin dynamics and cellular signaling interactions Used to investigate potential additive or synergistic effects of the two peptides at the molecular level 99% purity (individual components), independently verified by third-party HPLC testing COA available For research use only not for human or animal use WOLVERINE (BPC-157 5mg / TB-500 5mg) is supplied by Coastal Bio Labs as a research-grade compound for in vitro laboratory research use only
Licensed Peptides supplies 5-Amino-1MQ strictly for investigative and research purposes